147 related articles for article (PubMed ID: 16544905)
1. [Polyamines and mental diseases].
Siatkin SP; Svinarev VI; Zaletok SP; Fedoronchuk TV; Berezov TT
Vestn Ross Akad Med Nauk; 2006; (2):45-51. PubMed ID: 16544905
[TBL] [Abstract][Full Text] [Related]
2. Implication of the polyamine system in mental disorders.
Fiori LM; Turecki G
J Psychiatry Neurosci; 2008 Mar; 33(2):102-10. PubMed ID: 18330456
[TBL] [Abstract][Full Text] [Related]
3. Polyamines: The possible missing link between mental disorders and epilepsy (Review).
Baroli G; Sanchez JR; Agostinelli E; Mariottini P; Cervelli M
Int J Mol Med; 2020 Jan; 45(1):3-9. PubMed ID: 31746386
[TBL] [Abstract][Full Text] [Related]
4. Metabolic products of arachidonic acid in the central nervous system: possible role in mental disorders.
Mathé AA; Apéria B; Bergman P; Eberhard G; Jerling M; Lindström L; Sääf J; Undén F; Wetterberg L
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():958-62. PubMed ID: 2960211
[No Abstract] [Full Text] [Related]
5. The Potential Role of Polyamines in Epilepsy and Epilepsy-Related Pathophysiological Changes.
Liu J; Yu Z; Maimaiti B; Meng Q; Meng H
Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358946
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacology, biochemistry and clinical aspects of mental diseases].
Ancill RJ
Recenti Prog Med; 1974 Sep; 57(3):175-213. PubMed ID: 4479031
[No Abstract] [Full Text] [Related]
7. Emerging role of the FGF system in psychiatric disorders.
Riva MA; Molteni R; Bedogni F; Racagni G; Fumagalli F
Trends Pharmacol Sci; 2005 May; 26(5):228-31. PubMed ID: 15860368
[TBL] [Abstract][Full Text] [Related]
8. [Psychopharmacology of GABA].
Gerardy J
J Pharm Belg; 1982; 37(6):435-41. PubMed ID: 7161703
[TBL] [Abstract][Full Text] [Related]
9. [Possible physiological roles of polyamines at the level of the central nervous system].
Ientile R; Silvestri R; Nisticò G
Clin Ter; 1980 Sep; 94(6):695-706. PubMed ID: 7460504
[No Abstract] [Full Text] [Related]
10. Drug treatment of HIV associated neuropsychiatric syndromes.
Ayuso Mateos JL; Singh AN; Catalán J
Neurologia; 2000 Apr; 15(4):164-71. PubMed ID: 10846884
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic monitoring of psychotropic drugs and pharmacogenetic tests in psychiatry].
Voirol P; Eap CB; Baumann P
Rev Med Suisse Romande; 2000 Feb; 120(2):99-104. PubMed ID: 10748694
[No Abstract] [Full Text] [Related]
12. [Clinical significance of pharmacogenetics in psychiatry].
Skrętkowicz J; Barańska M; Rychlik-Sych M
Wiad Lek; 2013; 66(2 Pt 2):185-91. PubMed ID: 25775815
[TBL] [Abstract][Full Text] [Related]
13. [Effects of estrogen in the CNS].
Fedotova IuO; Sapronov NS
Usp Fiziol Nauk; 2007; 38(2):46-62. PubMed ID: 17578018
[TBL] [Abstract][Full Text] [Related]
14. [Neurochemical strategy in the study of the mechanism of action of currently used antipsychotic drugs].
Raevskiĭ KS
Vestn Ross Akad Med Nauk; 1992; (7):21-5. PubMed ID: 1281703
[No Abstract] [Full Text] [Related]
15. Coordination of cell development by the ornithine decarboxylase (ODC)/polyamine pathway as an underlying mechanism in developmental neurotoxic events.
Bell JM; Slotkin TA
Prog Brain Res; 1988; 73():349-63. PubMed ID: 3047803
[No Abstract] [Full Text] [Related]
16. Ascorbic Acid to Manage Psychiatric Disorders.
Moretti M; Fraga DB; Rodrigues ALS
CNS Drugs; 2017 Jul; 31(7):571-583. PubMed ID: 28600627
[TBL] [Abstract][Full Text] [Related]
17. Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action.
Jentsch JD; Roth RH; Taylor JR
Prog Brain Res; 2000; 126():433-53. PubMed ID: 11105661
[TBL] [Abstract][Full Text] [Related]
18. [Stimulant amino acids, glutamate receptors and pathology of the central nervous system].
Raevskiĭ KS
Patol Fiziol Eksp Ter; 1990; (1):3-9. PubMed ID: 1972271
[No Abstract] [Full Text] [Related]
19. [Substance regulation of behavior].
de Wied D
Ned Tijdschr Geneeskd; 1983 Jul; 127(29):1284-7. PubMed ID: 6136923
[No Abstract] [Full Text] [Related]
20. Experimental and clinical vectors in pharmacology.
Masserman JH
Curr Psychiatr Ther; 1976; 16():107-16. PubMed ID: 991623
[No Abstract] [Full Text] [Related]
[Next] [New Search]
